1. A novel mouse Smad4 mutation reduces protein stability and wild-type protein levels
- Author
-
Yijing Chen, Terry Magnuson, and Della Yee
- Subjects
Heterozygote ,TGF alpha ,Leupeptins ,Cysteine Proteinase Inhibitors ,GDF5 ,Biology ,medicine.disease_cause ,GDF1 ,Retinoblastoma-like protein 1 ,Mice ,Neoplasms ,Genetics ,medicine ,Animals ,Cycloheximide ,Allele ,Alleles ,Tissue homeostasis ,Genes, Dominant ,Smad4 Protein ,Mice, Knockout ,Protein Synthesis Inhibitors ,Mutation ,FGF10 ,Stem Cells ,Embryo, Mammalian ,Molecular biology ,Phenotype ,Signal Transduction - Abstract
Smad4 is a key signal transducer of the transforming growth factor-beta (TGF-beta) superfamily of growth factors that are critical regulators of embryonic patterning and adult tissue homeostasis. The biological activity of the TGF-beta signaling is tightly controlled at multiple levels, including the abundance of SMAD4 proteins. We previously recovered a novel allele of Smad4 in a gene-based screen in N-ethyl-N-nitrosourea (ENU)-mutagenized mouse embryonic stem cells. The mutation resulted in an unstable truncated protein that is degraded through proteasomal pathways. In the heterozygous state, this allele acts in a dominant negative fashion to reduce the wild-type protein level as well as signaling output. Biochemical characterization indicated that the truncated protein is able to form a complex with the wild-type protein, thus targeting it for proteasomal degradation as well. Phenotypic analyses of the heterozygous animals provided insight into the threshold requirement of Smad4-dependent signaling in vivo.
- Published
- 2006
- Full Text
- View/download PDF